These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38952606)
1. Mucormycosis, the Black Fungus in the Post-COVID-19 Pandemic: A Case Report with Review of Literature. Gandhewar AM; Hande A; Akolkar S Cureus; 2024 Jun; 16(6):e61473. PubMed ID: 38952606 [TBL] [Abstract][Full Text] [Related]
2. Mucormycosis, past and present: a comprehensive review. Gupta I; Baranwal P; Singh G; Gupta V Future Microbiol; 2023 Feb; 18():217-234. PubMed ID: 36970978 [TBL] [Abstract][Full Text] [Related]
3. Is Mucormycosis an inevitable complication of Covid-19 in India? Bhogireddy R; Krishnamurthy V; Jabaris S SL; Pullaiah CP; Manohar S Braz J Infect Dis; 2021; 25(3):101597. PubMed ID: 34289382 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of Clinical Manifestations, Pattern of Involvement, and Surgical Outcomes in Patients with Post Covid-19 Head and Neck Mucormycosis Infection among Patients Admitted To Namazi Hospital, Shiraz, Iran (2021-2022). Nahaei M; Motazedian G; Mohammadi AA; Davarpanah MA; Yazdanpanahi P; Ayareh N; Salari F; Keshtkar A World J Plast Surg; 2023; 12(3):64-72. PubMed ID: 38226199 [TBL] [Abstract][Full Text] [Related]
5. COVID-19-Associated Mucormycosis in a Tertiary Care Hospital in India: A Case Series. Singh S; Basera P; Anand A; Ozair A Cureus; 2022 Aug; 14(8):e27906. PubMed ID: 36110469 [TBL] [Abstract][Full Text] [Related]
6. Post-Covid alliance-mucormycosis, a fatal sequel to the pandemic in India. Nambiar M; Varma SR; Damdoum M Saudi J Biol Sci; 2021 Nov; 28(11):6461-6464. PubMed ID: 34305427 [TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Risk Factors, Diagnosis and Treatment of Mucormycosis (Black Fungus): A Review. Upadhayay P; Bansal K; Goyal A Curr Pharm Biotechnol; 2023; 24(13):1645-1656. PubMed ID: 36941816 [TBL] [Abstract][Full Text] [Related]
8. COVID19 associated mucormycosis: A review. Palanisamy PR; Elango D J Family Med Prim Care; 2022 Feb; 11(2):418-423. PubMed ID: 35360784 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and Mucormycosis: A Black Fungus Disaster? Chillana S; Mohit Chilana KA Indian J Dermatol; 2022; 67(5):535-538. PubMed ID: 36865825 [TBL] [Abstract][Full Text] [Related]
10. Glycemic Control and Mucormycosis during COVID-19 Pandemic in India a Study of Stage and Outcome. Sharma V; Kriplani K; Tuli IP; Sharma S; Narula A J Assoc Physicians India; 2023 Sep; 71(9):61-66. PubMed ID: 38700303 [TBL] [Abstract][Full Text] [Related]
11. Accidental finding of COVID-associated mucormycosis (CAM) in a patient presenting as toothache: A case report and review of literature. Gb P; B K; Sivapathasundharam B; Manodh P; Raj AT; Ghosh S; Dhungel S Clin Case Rep; 2023 May; 11(5):e7292. PubMed ID: 37151941 [TBL] [Abstract][Full Text] [Related]
12. Risks of mucormycosis in the current Covid-19 pandemic: a clinical challenge in both immunocompromised and immunocompetent patients. Monika P; Chandraprabha MN Mol Biol Rep; 2022 Jun; 49(6):4977-4988. PubMed ID: 35107737 [TBL] [Abstract][Full Text] [Related]
13. COVID-19 associated multisystemic mucormycosis from India: a multicentric retrospective study on clinical profile, predisposing factors, cumulative mortality and factors affecting outcome. Sahu M; Shah M; Mallela VR; Kola VR; Boorugu HK; Punjani AAR; Kumar RV; Kumar S; Manusrut M; Kumar SCR; Rathod R; Babu DM; Gonuguntla HK; Yedlapati GK; Mallu GR; Reddy YS; Reddy VV; Alwala S; Bongu VK; Kamalesh A; Kumar RNK; Jaishetwar GS; Bagapally RS; Srinivas JS; Balasubramaniam A; Rajagopalan BK; Pullikanti B; Prakasham SP; Nimmala P; Nagaraju B; Sahoo PR; Infection; 2023 Apr; 51(2):407-416. PubMed ID: 35922704 [TBL] [Abstract][Full Text] [Related]
14. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe. Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathological Study of Mucormycosis in COVID-19 Patients: Experience From a Tertiary Care Center in South India. Kandasamy S; Muthuraju S; Vasugi A; Chandrasekar M; Murugan R; Inbasekaran P; R P Cureus; 2022 Mar; 14(3):e23016. PubMed ID: 35419223 [TBL] [Abstract][Full Text] [Related]
16. Long-term Outcome of Coronavirus Disease-associated Mucormycosis: 1-year Follow-up Study from India. Agrawal P; Singh AP; Chakotiya PS; Kumar V; Gautam A; Kumar D J Assoc Physicians India; 2024 Jun; 72(6):44-48. PubMed ID: 38881134 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological association of mucormycosis in COVID 19 pandemic. Varshney M; Saxena A; Binnani N; Kumar V; Vyas SP Indian J Pathol Microbiol; 2023; 66(1):101-105. PubMed ID: 36656219 [TBL] [Abstract][Full Text] [Related]
18. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease. Rao C; R M J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509 [TBL] [Abstract][Full Text] [Related]
19. Antifungal Effect of Nanoparticles against COVID-19 Linked Black Fungus: A Perspective on Biomedical Applications. Gurunathan S; Lee AR; Kim JH Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293381 [TBL] [Abstract][Full Text] [Related]
20. COVID-19-associated mucormycosis: A review of an emergent epidemic fungal infection in the era of COVID-19 pandemic. Chamola V; Mohammadi R; Nair H; Goyal A; Patel A; Hassija V; Bassetti M; Narang P; Paredes R; Santos JR; Hashemi SJ; Sani MP; Shirani K; Alijani N; Naeini BA; Pourazizi M; Abtahi SH; Khorvash F; Khanjari M; Ahmadikia K J Res Med Sci; 2022; 27():57. PubMed ID: 36092491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]